Phase III Trial to Investigate Efficacy and Safety of Vilobelimab in Ulcerative Pyoderma Gangrenosum
Clinical trial NCT05964413 · TERMINATED
Trial details
- NCT number
- NCT05964413
- Sponsor
- InflaRx GmbH
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-01
- Primary completion
- 2025-07-11
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.